Middlekauff W Bradford
SEC-identified person · CIK 1214501 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Amanat Acquisition Corp. AMAN | Director | filed 2026–2026 |
| Tourmaline Bio, Inc. TRML | CBO, GC and Secretary | filed 2023–2025 |
| Immunovant, Inc. IMVT | General Counsel | filed 2019–2020 |
| PDS Biotechnology Corp PDSB | Senior VP, GC and Secretary | filed 2015–2019 |
| Medarex INC MEDX | SVP, General Counsel & Sec. | filed 2006–2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.